TABLE 3.
Protein |
---|
Cytoskeletal |
Filamin-A |
Neuroblast differentiation-associated protein AHNAK |
Microtubule-associated protein 4 |
Protein 4.1 |
Desmoglein-2 |
Src substrate cortactin |
Afadin |
CD2-associated protein |
Band 4.1-like protein 2 |
Filamin-B |
Membrane |
Hornerin |
4F2 cell-surface antigen heavy chain |
Sodium/potassium-transporting ATPase subunit alpha-1 |
Neutral amino acid transporter B(0) |
Hornerin |
Lipid regulation |
Fatty acid synthase |
Vigilin |
Nuclear transport |
Nucleoprotein TPR |
Lamina-associated polypeptide 2, isoforms beta/gamma |
Translation |
Elongation factor 1-alpha 1 |
PERQ amino acid-rich with GYF domain-containing protein 2 |
Eukaryotic translation initiation factor 4B |
La-related protein 1 |
Eukaryotic translation initiation factor 4 gamma 1 |
Ubiquitin-60S ribosomal protein L40 |
Bifunctional glutamate/proline-tRNA ligase |
Eukaryotic translation initiation factor 5 |
RNA processing |
Zinc finger CCCH-type antiviral protein 1 |
Ubiquitin-associated protein 2-like |
Protein PRRC2C |
Cold shock domain-containing protein E1 |
Plasminogen activator inhibitor 1 RNA-binding protein |
Ataxin-2-like protein |
Protein PRRC2A |
Ubiquitin-associated protein 2 |
Gem-associated protein 5 |
5′–3′ exoribonuclease 1 |
Nuclear fragile X mental retardation-interacting protein 2 |
Heterogenous nuclear ribonucleoprotein M |
ATP-dependent RNA helicase DDX3X |
RNA-binding protein 26 |
Orphans |
T-complex protein 1 subunit theta |
Band 4.1-like protein 3 |
Insulin receptor substrate 4 |
TOX high-mobility-group box family member 4 |
DNA-dependent protein kinase catalytic subunit |
Semenogelin-2 |
Protein CDV3 homolog |
Protein Lyric |
Semenogelin-1 |
Antigen KI-67 |
Histone H1.2 |
28-kDa heat- and acid-stable phosphoprotein |
Observed cellular biotinylated proteins were roughly categorized into groups as cytoskeletal, membrane, lipid regulation, nuclear transport, translation, RNA processing, and orphan proteins. Within each group, lists are ordered based on summed observed detection signals (percent WT BirA* plus percent ΔMA BirA* from Table 2).